You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematological Neoplasms

Showing 1 - 25 of 2,502
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Endothelial Cell Dysfunction and Outcome Project for

Not yet recruiting
  • Hematological Neoplasm
  • Endothelial Dysfunction
  • Sublingual in vivo microscopy with the Glycocheck microscope
  • (no location specified)
Aug 14, 2022

Cancer Survivorship in Hematologic Malignancies

Not yet recruiting
  • Cancer Survivors
  • questionnaire
  • Assiut, Egypt
    Assiut University
Mar 10, 2023

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    Mature B-cell Tumors Trial (Nemtabrutinib)

    Not yet recruiting
    • Mature B-cell Neoplasms
    • (no location specified)
    Jan 13, 2023

    Hematologic Malignancy Trial in Tianjin (BR108 injection)

    Recruiting
    • Hematologic Malignancy
    • BR108 injection
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Aug 25, 2023

    Oral Complications in Hematological Malignancies

    Not yet recruiting
    • Hematologic Malignancy
      • Assiut, Egypt
        Assiut university
      Mar 6, 2023

      Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

      Not yet recruiting
      • Hematological Malignancies
      • Allogeneic T cell progenitors, cultured ex-vivo
      • (no location specified)
      Mar 2, 2023

      Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

      Not yet recruiting
      • Non-hodgkin's Lymphoma
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Sep 27, 2023

      Hematological Malignancies Trial in Limoges ("Blend of ginger and lemon essential oils", "Neutral oil")

      Not yet recruiting
      • Hematological Malignancies
      • "Blend of ginger and lemon essential oils", "Neutral oil"
      • Limoges, France
        University Hospital, Limoges
      Nov 20, 2023

      Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

      Not yet recruiting
      • Hematological Malignancy
      • Solid Tumor
      • (no location specified)
      Apr 24, 2023

      Toxoplasmosis Trial in Sohag (toxoplasma igG)

      Not yet recruiting
      • Toxoplasmosis
      • toxoplasma igG
      • Sohag, Egypt
        Sohag university Hospital
      Jul 19, 2023

      Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

      Not yet recruiting
      • Relapsed/Refractory Chronic Lymphocytic Leukemia
      • Tianjin, Tianjin, China
        Institute of Hematology and Blood Diseases Hospital, Chinese Aca
      Jul 13, 2023

      Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)

      Not yet recruiting
      • Hematological Malignancy
      • Neutropenia
      • Morgantown, West Virginia
        Aaron Cumpston
      Sep 12, 2022

      Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia (AML)
      • NTQ2494 tablet
      • Tianjin, Tianjin, China
        Hematology Hospital of the Chinese Academy of Medical Sciences
      Sep 17, 2023

      Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

      Recruiting
      • Neoplasms
      • +3 more
      • RD13-02 cell infusion
      • Wuhan, Hubei, China
        Union Hospital, Huazhong University of Science and Technology
      Jun 8, 2023

      Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

      Recruiting
      • Lymphoma
      • +2 more
      • Resistance Training
      • Aerobic Exercise
      • Tampa, Florida
        Moffitt Cancer Center
      Feb 28, 2023

      COVID-19 Infection in Hematological Malignancies Patients Trial in Italy

      Recruiting
      • COVID-19 Infection in Hematological Malignancies Patients
        • Brescia, Italy
        • +5 more
        Oct 25, 2022

        Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

        Recruiting
        • Hematological Neoplasms
        • Recurrence
        • Peg interferon alfa-2b
        • Shanghai, Shanghai, China
          Shanghai Jiao Tong University Affilated First People's Hospital
        Oct 10, 2021

        Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)

        Recruiting
        • Hematological Malignancy
        • COVID-19
        • Anti-COVID-19 Antibody SA55 for Injection
        • Beijing, Beijing, China
          Beijing Boren Hospital
        Jan 9, 2023

        Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

        Active, not recruiting
        • Hematologic Neoplasm
        • Neoplasms
        • Gainesville, Florida
        • +2 more
        Jan 12, 2023

        "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

        Recruiting
        • Mantle-cell Lymphoma
        • B Cell Chronic Lymphocytic Leukemia
          • Monza, MB, Italy
            Andrea Aroldi
          May 24, 2023

          Hematological Malignancies, Thrombocytopenia Trial in Atlanta, Decatur (EACA, Platelet transfusion)

          Terminated
          Has Results
          • Hematological Malignancies
          • Thrombocytopenia
          • EACA
          • Platelet transfusion
          • Atlanta, Georgia
          • +1 more
          Jun 26, 2022

          Hematological Tumors Trial in Beijing (TQB2825 injection)

          Recruiting
          • Hematological Tumors
          • TQB2825 injection
          • Beijing, Beijing, China
            Beijing Cancer Hospital
          Aug 4, 2022

          Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

          Recruiting
          • Solid Tumor
          • Hematological Malignancy
          • East Melbourne, Victoria, Australia
          • +4 more
          Jan 11, 2023

          Hematological Malignancies Trial (Anti-CD7 CAR-T)

          Not yet recruiting
          • Hematological Malignancies
          • Anti-CD7 CAR-T
          • (no location specified)
          Jul 8, 2022